company background image
CIPLA logo

Cipla NSEI:CIPLA Stock Report

Last Price

₹1.47k

Market Cap

₹1.2t

7D

-0.9%

1Y

-1.7%

Updated

28 May, 2025

Data

Company Financials +

CIPLA Stock Overview

Engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. More details

CIPLA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends5/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

₹1.64k
FV
10.5% undervalued intrinsic discount
7.85%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
21users have followed this narrative
about 11 hours ago author updated this narrative

Cipla Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cipla
Historical stock prices
Current Share Price₹1,468.50
52 Week High₹1,702.05
52 Week Low₹1,335.00
Beta0.16
1 Month Change-5.57%
3 Month Change1.90%
1 Year Change-1.68%
3 Year Change49.31%
5 Year Change129.02%
Change since IPO45,407.61%

Recent News & Updates

Earnings Beat: Cipla Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 16
Earnings Beat: Cipla Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Cipla Limited (NSE:CIPLA) Investors Are Less Pessimistic Than Expected

Apr 15
Cipla Limited (NSE:CIPLA) Investors Are Less Pessimistic Than Expected

Recent updates

Earnings Beat: Cipla Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 16
Earnings Beat: Cipla Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Cipla Limited (NSE:CIPLA) Investors Are Less Pessimistic Than Expected

Apr 15
Cipla Limited (NSE:CIPLA) Investors Are Less Pessimistic Than Expected

With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

Mar 25
With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

These 4 Measures Indicate That Cipla (NSE:CIPLA) Is Using Debt Safely

Feb 17
These 4 Measures Indicate That Cipla (NSE:CIPLA) Is Using Debt Safely

Why Investors Shouldn't Be Surprised By Cipla Limited's (NSE:CIPLA) Low P/E

Jan 13
Why Investors Shouldn't Be Surprised By Cipla Limited's (NSE:CIPLA) Low P/E

We Ran A Stock Scan For Earnings Growth And Cipla (NSE:CIPLA) Passed With Ease

Dec 07
We Ran A Stock Scan For Earnings Growth And Cipla (NSE:CIPLA) Passed With Ease
author-image

Aspirational Inhalation Launches And African Expansion Propel Growth Ambitions

Planned respiratory therapies and product launches could drive increased revenue and enhance the chronic therapy segment's growth.

Cipla Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Nov 01
Cipla Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Cipla Limited's (NSE:CIPLA) Share Price Could Signal Some Risk

Sep 29
Cipla Limited's (NSE:CIPLA) Share Price Could Signal Some Risk

Cipla (NSE:CIPLA) Is Increasing Its Dividend To ₹13.00

Jun 06
Cipla (NSE:CIPLA) Is Increasing Its Dividend To ₹13.00

Shareholder Returns

CIPLAIN PharmaceuticalsIN Market
7D-0.9%-0.4%0.5%
1Y-1.7%13.1%3.7%

Return vs Industry: CIPLA underperformed the Indian Pharmaceuticals industry which returned 13.6% over the past year.

Return vs Market: CIPLA underperformed the Indian Market which returned 3.2% over the past year.

Price Volatility

Is CIPLA's price volatile compared to industry and market?
CIPLA volatility
CIPLA Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement7.0%
Market Average Movement6.9%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.6%

Stable Share Price: CIPLA has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: CIPLA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
193527,764Umang Vohrawww.cipla.com

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry.

Cipla Limited Fundamentals Summary

How do Cipla's earnings and revenue compare to its market cap?
CIPLA fundamental statistics
Market cap₹1.19t
Earnings (TTM)₹52.73b
Revenue (TTM)₹271.45b
22.5x
P/E Ratio
4.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CIPLA income statement (TTM)
Revenue₹271.45b
Cost of Revenue₹89.29b
Gross Profit₹182.16b
Other Expenses₹129.44b
Earnings₹52.73b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)65.28
Gross Margin67.11%
Net Profit Margin19.42%
Debt/Equity Ratio0.3%

How did CIPLA perform over the long term?

See historical performance and comparison

Dividends

0.9%
Current Dividend Yield
20%
Payout Ratio

Does CIPLA pay a reliable dividends?

See CIPLA dividend history and benchmarks
When do you need to buy CIPLA by to receive an upcoming dividend?
Cipla dividend dates
Ex Dividend DateJun 27 2025
Dividend Pay DateAug 15 2025
Days until Ex dividend29 days
Days until Dividend pay date78 days

Does CIPLA pay a reliable dividends?

See CIPLA dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/28 07:07
End of Day Share Price 2025/05/28 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cipla Limited is covered by 70 analysts. 36 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Prashant NairAmbit Capital
null nullAnand Rathi Shares and Stock Brokers Limited